I-Mab Expands U.S. Footprint with New R&D Site in San Diego
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...
Source: prnewswire.com
Formulation Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Formulation Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Formulation Research Today - Breaking & Trending Today
I-Mab establishing new site in San Diego
I-Mab is establishing a new site in San Diego that will focus on translational medicine and formulation research.
Source: scienceboard.net
Formulation Scientist Job Opening in New Haven CT (not for
molecules ‒ known as PROTAC® (PROteolysis TArgeting Chimeras) 8210; aimed at degrading disease-causing cellular proteins via proteolysis. Based on innovative research conducted at Yale University by Dr. Craig Crews , Founder and Chief Scientific Advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. The proprietary PROTAC® -based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting “undru...
Source: mitbbs.com